Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price

Instead of betting on which single pharmaceutical company wins a drug race, this company benefits as the industry grows by supplying the proprietary packaging.

Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price

Published August 5, 2026 · Category: Finance

Overview

Instead of betting on which single pharmaceutical company wins a drug race, this company benefits as the industry grows by supplying the proprietary packaging.

Source

Originally published at www.cnbc.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.